BVS Q2 2022 Earnings — Bioventus Inc. Revenue & Financial Results | Market Cap Arena

BVSBioventus Inc.

$593M

Q2 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$140M+27.8% YoY

Gross Profit

$97M68.9% margin

Operating Income

-$3M-2.4% margin

Net Income

-$7M-5.2% margin

EPS (Diluted)

$-0.11

QoQ Revenue Growth

+19.6%

Cash Flow

Operating Cash Flow

$3M

Free Cash Flow

$909,000

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$689M

Stockholders' Equity

$448M

Cash & Equivalents

$41M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$140M	$110M	+27.8%
Gross Profit	$97M	$76M	+26.7%
Operating Income	-$3M	-$6M	+42.4%
Net Income	-$7M	-$4M	-75.8%

Revenue Segments

Pain Treatments

$64M46%

Restorative Therapies

$40M28%

Surgical Solutions

$37M26%

Geographic Segments

UNITED STATES

$126M90%

Non-US

$14M10%